Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 277 - Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
Patents for C07D 277 - Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings (33,621)
12/2005
12/01/2005US20050267173 Serine protease inhibitors
12/01/2005US20050267171 Alpha-and beta-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
12/01/2005US20050267163 Vanilloid receptor ligands and their use in treatments
12/01/2005US20050267156 Broadspectrum 2-amino-benzothiazole sulfonamide hiv protease inhibitors
12/01/2005US20050267151 Hepatitis C; preparing 8-bromo-7-alkoxyquinolines 2-substituted with a hetercyclic ring having an amine, carbamate, amine or urea group an 4-substituted with a 3-prolineoxy- group or derivative; intermediates
12/01/2005US20050267149 Benzoic acid derivatives as modulators of ppar alpha and gamma
12/01/2005US20050267123 6-Membered heterocyclic compounds useful for selective inhibition of the coagulation cascade
12/01/2005US20050267110 Propane-1, 3-dione derivative
12/01/2005US20050267032 Sulfone-containing prodrugs
12/01/2005DE102004023522A1 Substituierte Cyclohexyl-1,4-diamin-Derivate Substituted cyclohexyl-1,4-diamine derivatives
12/01/2005CA2567343A1 N-cyclic sulfonamido inhibitors of gamma secretase
11/2005
11/30/2005EP1600442A1 Heteroarylcarbamoylbenzene derivative
11/30/2005EP1599449A2 Carbamic acid compounds comprising a bicyclic heteroaryl group as hdac inhibitors
11/30/2005EP1091943B1 Non-peptidyl inhibitors of vla-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases
11/30/2005CN1703408A Substituted (thiazol-2-yl) -amide or sulfonamide as glycokinase activators useful in the treatment of type 2 diabetes
11/30/2005CN1703407A Inhibitors of fatty acid amide hydrolase
11/30/2005CN1703397A Sulfonylamino-acetic acid derivatives and their use as orexin receptor antagonists
11/30/2005CN1703395A Aryl and heteroaryl compounds and methods to modulate coagulation
11/30/2005CN1229377C Spiro [Piperidine-4,1'-pyrrolo[3,4-c] pyrrole]
11/30/2005CN1229362C Bicyclic guanidine derivatives and therapeutic uses thereof
11/30/2005CN1229361C Preparation method of 2-(hydrocarbon) imido (amine)-4-thiazolidone hydrochloride
11/30/2005CN1229360C Preparation method of 2-(hydrocarbon) imido (amine)-4-thiazolidone
11/30/2005CN1229359C Catalytic process for prepn. of thiazole derivatives
11/29/2005US6969766 PNA monomer and precursor
11/29/2005US6969727 Obesity; osteoporosis
11/29/2005US6969715 6-membered heterocyclic compounds useful for selective inhibition of the coagulation cascade
11/29/2005US6969711 Cyclic diamine compounds and medicine containing the same
11/24/2005WO2005111007A1 Thiazole compound and use thereof
11/24/2005WO2005111006A1 Ritonavir analogous compound useful as retroviral protease inhibitor, preparation of the ritonavir analogous compound and pharmaceutical composition for the ritonavir analogous compound.
11/24/2005WO2005110980A2 Aryl sulfones and uses related thereto
11/24/2005WO2005110974A1 Substituted cyclohexyl-1,4-diamine derivatives
11/24/2005WO2005110971A1 Heteroaryl substituted cyclohexyl-1,4-diamine derivatives
11/24/2005WO2005090296A3 N-substituted benzene sulfonamides
11/24/2005WO2005086904A3 Therapeutic modulation of ppar (gamma) activity
11/24/2005WO2005086638A3 Analogs exhibiting inhibition of cell proliferation, methods of making, and uses thereof
11/24/2005WO2005084222A3 Synthesis of epothilones, intermediates thereto, analogues and uses thereof
11/24/2005WO2005076990A3 Process for preparing 2-aminothiazole-5-carboxamides useful as kinase inhibitors
11/24/2005US20050261503 Heteroaromatic glucokinase activators
11/24/2005US20050261501 e.g. 1-({[9-(hydroxymethyl)-3-oxaspiro[5.5]undec-9-yl]amino}acetyl)-2-pyrrolidinecarbonitrile; dipeptidyl-peptidase IV inhibitor; antidiabetic, hypoglycemic agent; non-insulin dependent diabetes, obesity
11/24/2005US20050261315 tyrosine kinase inhibitors such as N-(3-tert-butylisoxazol-5-yl)-2-(4-(benzyloxy)phenyl)acetamide, used for treating and preventing conditions and diseases, such as cancer, hematologic malignancies, cardiovascular disease, inflammation or multiple sclerosis
11/24/2005US20050261305 Cyclic protein tyrosine kinase inhibitors
11/24/2005US20050261294 Substituted heteroaryl derivatives, compositions, and methods of use
11/24/2005US20050261291 1-Cyclopropylmethyl-4-[2-(3,3,5,5-tetramethylcyclohexyl)phenyl]piperazine or a salt or hydrate; exhibit excellent cell adhesion inhibitory action or cell infiltration inhibitory action; for treating inflammatory diseases and autoimmune diseases such as inflammatory bowel diseases and rheumatoid arthritis
11/24/2005US20050261290 Novel compounds of proline and morpholine derivatives
11/24/2005US20050261276 Novel sulphones for inhibition of gamma secretase
11/24/2005US20050261273 Substituted urea and carbamate, phenacyl-2-hydroxy-3-diaminoalkane, and benzamide-2-hydroxy-3-diaminoalkane aspartyl-protease inhibitors
11/24/2005US20050261242 nitroso derivatives of drugs such as antiinflammatory agents, antibiotics, expectorants, mucolytic agents, antidiabetics, antitumor, viricides, enzyme inhibitors bronchodilators and antiulcer agents; oxidative and endothelial stress dysfunction; free radicals scavenger
11/24/2005US20050260126 Diagnostic probes and remedies for diseases with accumulation of prion protein, and stains for prion protein
11/24/2005CA2566625A1 Thiazole compound and use thereof
11/24/2005CA2566212A1 Heteroaryl-substituted cyclohexyl-1,4-diamine derivatives
11/24/2005CA2561525A1 Aryl sulfones and uses related thereto
11/23/2005EP1598350A1 Pyrrolidines and thiazolidines derivatives, their preparation and their use in the treatment of hyperglycaemia and of type II Diabetis
11/23/2005EP1597322A2 Metal complexes as light-absorbing compounds in the information layer of optical data carriers
11/23/2005EP1597248A2 Sulfonamide derivatives as ppar modulators
11/23/2005EP0811007B1 Pyrazol-4-yl-benzoyl derivatives and their use as herbicides
11/23/2005CN1701064A Benzothiazole derivatives having beta-2-adrenoreceptor agonist activity
11/23/2005CN1701061A New compounds for the inhibition of rotamases and use thereof
11/23/2005CN1699355A 2,3,5-trisubstituted-4-thiazolidone compounds and pharmaceutical use thereof
11/23/2005CN1699354A 2,3,5-trisubstituted-4-thiazolidone compounds and pharmaceutical use thereof
11/23/2005CN1228327C Carboxylic acid derivatives and drugs containing the same
11/22/2005US6967251 Reagents for labeling biomolecules having aldehyde or ketone moieties
11/22/2005US6967214 Inhibitors of IMPDH enzyme
11/22/2005CA2187174C .alpha.-substituted phenylacetic acid derivative, process for producing the same, and agricultural bactericide containing the same
11/22/2005CA2162122C Use of glycine-n,n-diacetic acid derivatives as biodegradable complexing agents for alkaline earth and heavy metal ions, and method of preparing them
11/22/2005CA2068066C Herpesvirus particles and vaccine
11/17/2005WO2005108383A2 Multi-lamellar liquid crystal emulsion system
11/17/2005WO2005108381A1 Synthesis and uses of synephrine derivatives
11/17/2005WO2005108370A1 Benzene compounds
11/17/2005WO2005108368A1 Adamantyl-acetamide derivatives as inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme
11/17/2005WO2005108359A1 Novel compounds of proline and morpholine derivatives
11/17/2005WO2005107762A2 Certain chemical entities, compositions, and methods
11/17/2005WO2005107464A2 Compounds and compositions as cathepsin s inhibitors
11/17/2005WO2005085177A3 Biaryl amino acids and their use in dna binding oligomers
11/17/2005US20050256170 EP receptor (for which the endogenous ligand is prostaglandin E2, PGE2); e.g. (4-[(5-Phenyl-furan-2-carbonyl)-amino]-phenyl)-acetic acid or 5-Phenyl-furan-2-carboxylic acid [3-(1H-tetrazol-5-yl)-phenyl]-amide; dysmenorrhoea, preterm labour, glaucoma, immune disorders, inflammatory disorders
11/17/2005US20050256166 Nitrogen-containing compounds
11/17/2005US20050256030 Heterocyclic self-immolative linkers and conjugates
11/17/2005US20050255055 Protecting human and animal hair or skin from UV radiation by applying a 4,4-disubstituted -1,3-butadienylamine; 4,4-substituents may be the same or different and are cyano, ester, sec. or tert. amide, ketone and/or sulfone, e.g., 4,4-bis(hexyloxycarbonyl)-N,N-diethyl-1,3-butadienylamine
11/17/2005CA2568241A1 Adamantyl-acetamide derivatives as inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme
11/17/2005CA2565843A1 Novel compounds of proline and morpholine derivatives
11/17/2005CA2565695A1 Certain chemical entities and compositions for use in the treatment of a cellular proliferative disease or disorder
11/17/2005CA2564506A1 Multi-lamellar liquid crystal emulsion system
11/16/2005EP1595871A2 Metabotropic glutamate receptor antagonists and their use for treating central nervous system diseases
11/16/2005EP1594867A2 Phenylacetamides and their use as glucokinase modulators
11/16/2005EP1594866A1 Antiproliferative 2-(sulfo-phenyl)-aminothiazole derivatives
11/16/2005EP1594854A2 Thiazolyl-based compounds useful as kinase inhibitors
11/16/2005EP1594505A2 Phenylglycine derivatives useful as serine protease inhibitors
11/16/2005EP1379138B1 Liquid formulations for dermal application in treatment of parasitic insects in animals
11/16/2005EP1326850B1 A process for the preparation of bis-benzazolyl compounds
11/16/2005CN1227244C Herbicidal benzoyl derivatives
11/16/2005CN1227229C Ethylene derivatives and pest controlling agents containing same
11/15/2005US6965034 Deoxygenation of epothilone A or B, to form desoxyepothilone used as nontoxic anticarcinogenic agents
11/15/2005US6964973 Nonsteroidal agonists and antagonists
11/15/2005CA2387517C Novel biaryl ether derivatives useful as monoamine reuptake inhibitors
11/10/2005WO2005106868A1 Metal chelates and their use in optical recording media having high storage capacity
11/10/2005WO2005105765A1 Nitric oxide donors and uses thereof
11/10/2005WO2005105764A1 Butanoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic applications threreof
11/10/2005WO2005105746A1 Organometallic complex, luminous solid, organic el element and organic el display
11/10/2005WO2005105729A1 Polyamine analogs that activate antizyme frameshifting
11/10/2005WO2005105726A1 Novel compounds, their preparation and use
11/10/2005WO2005105724A1 Hexenoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic applications thereof
1 ... 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 ... 337